CMD's current price/earnings ratio is 98.18, which is higher than 94.24% of US stocks with positive earnings.
With a year-over-year growth in debt of 307.65%, Cantel Medical Corp's debt growth rate surpasses 94.59% of about US stocks.
Cantel Medical Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.68%, greater than the shareholder yield of only 12.22% of stocks in our set.
If you're looking for stocks that are quantitatively similar to Cantel Medical Corp, a group of peers worth examining would be CNMD, GCP, INGN, KAI, and CSTE.
Cantel Medical Corporation provides infection prevention and control products and services in the healthcare market. The company operates in 5 segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, Specialty Packaging. The company was founded in 1963 and is based in Little Falls, New Jersey.
CMD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for CMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cantel Medical Corp ranked in the 10th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 93.17%. The most interesting components of our discounted cash flow analysis for Cantel Medical Corp ended up being:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 67. Notably, its equity weight is greater than just 20.12% of US equities in the Healthcare sector yielding a positive free cash flow.
Its compound free cash flow growth rate, as measured over the past 5.44 years, is -0.11% -- higher than only 16.09% of stocks in our DCF forecasting set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CMD, try SRDX, CRY, EHC, LCTC, and LHCG.
Shares of Cantel Medical (NYSE:CMD) were flat in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share decreased 70.91% over the past year to $0.16, which missed the estimate of $0.37.Revenue of $236,933,000 rose by 3.67% from the same period last year, which missed the estimate of $242,630,000.Outlook Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.Details Of The Call Date: Jun 04, 2020View more earnings on CMDTime: 08:30 AMET Webcast URL: https://www.webcaster4.com/Webcast/Page/2203/34733Technicals 52-week high: $93.8752-week low: $20.81Price action over last quarter: down 16.65%Company Overview Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infect...